-+ 0.00%
-+ 0.00%
-+ 0.00%

Wells Fargo Maintains Equal-Weight on Nurix Therapeutics, Lowers Price Target to $20

Benzinga·11/04/2026 15:27:34
Listen to the news
Wells Fargo analyst Derek Archila maintains Nurix Therapeutics (NASDAQ:NRIX) with a Equal-Weight and lowers the price target from $25 to $20.